Given that many clients can not fast without a lot of preparation, the majority of my clients start out with a gentle detox program that takes considerably more time, but works.  These gradients have been outlined under the healing programs for the chronically ill, acutely ill, etc.

To help rebuild poorly functioning organs, I sometimes use a specialized group of food supplements called protomorphogens.  These are not readily available to the general public and perhaps should not be casually purchasable like vitamins, because, as with many prescription drugs, supervision is usually necessary for their successful use.  If the FDA ever succeeds at making protomorphogens unavailable to me, I could still have very good results. (At this time the Canadian authorities do not allow importation of protomorphogens for resale, though individuals can usually clear small shipments through Canada Customs if for their own personal use.) But protomorphogens do facilitate healing and sometimes permit healing to occur at a lower gradient of handling.  Without them a body might have to fast to heal, with the aid of protomorphogens a person might be able to get better without fasting.  And if protomorphogens are used (chewed up—­ugh!) while fasting, healing is accelerated.

Protomorphogens are made from freeze-dried, organically-raised animal organ meats (usually calf or lamb) combined with very specific vitamins, herbs and other co-factors to potentiate the effect.  I view protomorphogens as containing nutritional supplementation specific for the rebuilding of the damaged organ.

Doctor Royal Lee, a medical genius who developed protomorphogens therapy in the 50s and who spent several stints in prison in exchange for his benevolence and concern for human well-being, also founded the company that has supplied me with protomorphogens.  After decades of official persecution and denial of the efficacy of protomorphogens by the power structure, it looks like they are about to finally have their day.  As I write this book cutting-edge medical research companies are developing therapies using concentrated animal proteins (protomorphogens) to treat arthritis, multiple sclerosis, eye inflamations and juvenile diabetes.  The researchers talk as though they are highly praiseworthy for “discovering” this approach.

Unfortunately, this development is likely to cut two ways.  On one hand, it vindicates Dr. Lee; on the other, when these drug companies find a way to patent their materials, they may finally succeed at forcing protomorphogens (currently quite inexpensive) off the non-prescription market and into the restricted and profitable province of the MD.